Publicaciones en las que colabora con Marta Rodríguez Romero (19)

2024

  1. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition

    Biochemical Pharmacology

2022

  1. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers

    Cancers, Vol. 14, Núm. 14

2020

  1. Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment

    Cancers, Vol. 12, Núm. 9, pp. 1-34

  2. Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma

    HEPATOBILIARY SURGERY AND NUTRITION

  3. Liver and gastrointestinal cancers

    DRUG EFFLUX PUMPS IN CANCER RESISTANCE PATHWAYS: FROM MOLECULAR RECOGNITION AND CHARACTERIZATION TO POSSIBLE INHIBITION STRATEGIES IN CHEMOTHERAPY (ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD), pp. 197-250

  4. Molecular bases of drug resistance in hepatocellular carcinoma

    Cancers, Vol. 12, Núm. 6, pp. 1-26

  5. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach

    Cancers, Vol. 12, Núm. 6, pp. 1-30

  6. Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5

2018

  1. Chemoresistance and chemosensitization in cholangiocarcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453

  2. Molecular bases of the poor response of liver cancer to chemotherapy

    Clinics and Research in Hepatology and Gastroenterology

2012

  1. Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta

    Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283

  2. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors

    Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704

  3. Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy

    Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427

2011

  1. Further characterization of the electrogenicity and ph sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3

    Molecular Pharmacology, Vol. 79, Núm. 3, pp. 596-607

2008

  1. Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in rat hepatocytes

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 295, Núm. 1

2007

  1. Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases

    Biochemical Pharmacology, Vol. 73, Núm. 9, pp. 1394-1404

2006

  1. OATP8/1B3-mediated cotransport of bile acids and glutathione: An export pathway for organic anions from hepatocytes?

    Journal of Biological Chemistry, Vol. 281, Núm. 41, pp. 30326-30335

2005

  1. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system

    Antiviral Research, Vol. 68, Núm. 2, pp. 75-83

2002

  1. Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system

    Antiviral Chemistry and Chemotherapy, Vol. 13, Núm. 6, pp. 371-380